Plain-English translation of NCT06270498 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing sucrosomial iron, a special form of iron taken by mouth, to see if it can improve how far people with heart failure can walk and how they feel day-to-day. Researchers know that intravenous iron (given through an IV) helps heart failure patients, but regular oral iron pills don't work as well. This medication uses a unique design that might allow your body to absorb it better, even when heart failure makes that difficult.
Many heart failure patients have low iron levels, which makes it harder to exercise and reduces their quality of life. While IV iron works, it's not ideal for long-term use. This study exists to find out if this medication could offer a better, easier-to-take option that works as well as IV iron.
You likely qualify if…
You likely don't qualify if…
You would take either the medication or a placebo pill by mouth for several months while attending study visits to check your health and exercise capacity. At these visits, you'll walk for 6 minutes to see how far you can go, answer questions about how you're feeling and your quality of life, and have blood tests to monitor your iron levels and heart health. The study team will make sure the medication is safe for you and working as intended.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Italy